Correlations of growth arrest specific 6 and C1q/TNF-related protein 4 with carotid atherosclerosis in patients with type 2 diabetes

JIANG Nengmei; GUAN Xinjuan; YANG Shezhen

doi:10.7619/jcmp.20223211

Journal of Clinical Medicine in Practice > 2023 > 27(5): 123-127. > DOI: 10.7619/jcmp.20223211

JIANG Nengmei, GUAN Xinjuan, YANG Shezhen. Correlations of growth arrest specific 6 and C1q/TNF-related protein 4 with carotid atherosclerosis in patients with type 2 diabetes[J]. Journal of Clinical Medicine in Practice, 2023, 27(5): 123-127. DOI: 10.7619/jcmp.20223211

Citation:

PDF (690 KB)

Correlations of growth arrest specific 6 and C1q/TNF-related protein 4 with carotid atherosclerosis in patients with type 2 diabetes

Department of Endocrinology, Haimen District People's Hospital in Nantong City of Jiangsu Province, Haimen, Jiangsu, 226100

More Information

Received Date: October 27, 2022
Revised Date: November 29, 2022
Available Online: April 06, 2023

Graphical Abstract

Abstract

Abstract

Objective
To evaluate the correlations of growth arrest specific 6 (GAS6) and C1q/TNF-related protein 4 (CTRP4) levels with carotid atherosclerosis (CAS) in patients with type 2 diabetes (T2DM).
Methods
A total of 60 T2DM patients with CAS confirmed by ultrasound were retrospectively selected as T2DM+CAS group, and 60 T2DM patients without CAS confirmed by ultrasound were selected as T2DM group according to a matching ratio of 1 to 1 in gender as well as addition and subtraction of age for 2 years. A questionnaire was developed to collect clinical data of the patients. Plasma GAS6 and serum CTRP4 levels were measured by enzyme-linked immunosorbent assay (ELISA). Logistic regression analysis was used to evaluate the risk factors of CAS in T2DM patients. The receiver operating characteristic (ROC) curve was drawn and the area under the curve (AUC) was calculated to evaluate the predictive efficacy of plasma GAS6 level and serum CTRP4 level for CAS in T2DM patients.
Results
There were no significant differences in age, body mass index, waist circumference, smoking, blood pressure and levels of relevant biochemical indicators between the two groups (P>0.05). The prevalence of hypertension in the T2DM+CAS group was higher than that in the T2DM group, and the levels of GAS6 and CTRP4 were lower than those in the T2DM group, and the differences were statistically significant (P < 0.05). Logistic regression analysis showed that increase of every 1 ng/mL in GAS6 and CTRP4 levels respectively leaded to 0.508 times (OR=0.508, 95%CI, 0.345 to 0.747, P=0.001) and 0.883 times of decrease in the risk of CAS in T2DM patients (OR=0.883, 95%CI, 0.819 to 0.952, P=0.001). Hypertension increased the risk of CAS in T2DM patients by 3.051 times (OR=3.051, 95%CI, 1.438 to 6.473, P=0.004). The maximum Youden index of GAS6 or CTRP4 alone and their combination in predicting CAS in T2DM patients was 0.417, 0.384 and 0.517, respectively, with the corresponding sensitivity of 85.0%, 81.7% and 81.7%, and the specificity of 58.3%, 56.7% and 70.0%, respectively.
Conclusion
Plasma GAS6 and CTRP4 levels are negatively correlated with the risk of CAS in T2DM patients, and the combination of plasma GAS6 and CTRP4 has a good predictive value for CAS in T2DM patients.
- type 2 diabetes mellitus,
- carotid atherosclerosis,
- growth arrest specific 6,
- C1q/TNF-related protein 4,
- hypertension

FullText(HTML)

References (20)

References

[1]	LAM TOI P, ANOTHAISINTAWEE T, CHAIKLEDKAEW U, et al. Preventive role of diet interventions and dietary factors in type 2 diabetes mellitus: an umbrella review[J]. Nutrients, 2020, 12(9): 2722. doi: 10.3390/nu12092722
[2]	LI Y Z, TENG D, SHI X G, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study[J]. BMJ, 2020, 369: m997.
[3]	BRAGG F, HOLMES M V, IONA A, et al. Association between diabetes and cause-specific mortality in rural and urban areas of China[J]. JAMA, 2017, 317(3): 280-289. doi: 10.1001/jama.2016.19720
[4]	KRAMER C M, TREIMAN G S. Vulnerable plaque in carotid arteries without "significant" stenosis: unmasking the hidden links to stroke[J]. J Am Coll Cardiol, 2020, 76(19): 2223-2225. doi: 10.1016/j.jacc.2020.09.531
[5]	American Diabetes Association. Improving care and promoting health in populations: Standards of medical care in diabetes-2018[J]. Diabetes Care, 2018, 41(suppl 1): S7-S12.
[6]	ROBINS R S, LEMARIÉ C A, LAURANCE S, et al. Vascular Gas6 contributes to thrombogenesis and promotes tissue factor up-regulation after vessel injury in mice[J]. Blood, 2013, 121(4): 692-699. doi: 10.1182/blood-2012-05-433730
[7]	SARVER D C, STEWART A N, RODRIGUEZ S, et al. Loss of CTRP4 alters adiposity and food intake behaviors in obese mice[J]. Am J Physiol Endocrinol Metab, 2020, 319(6): E1084-E1100. doi: 10.1152/ajpendo.00448.2020
[8]	RODRIGUEZ-GUTIERREZ R, GONZALEZ-GONZALEZ J G, ZUÑIGA-HERNANDEZ J A, et al. Benefits and harms of intensive glycemic control in patients with type 2 diabetes[J]. BMJ, 2019, 367: l5887.
[9]	YAHAGI K, KOLODGIE F D, LUTTER C, et al. Pathology of human coronary and carotid artery atherosclerosis and vascular calcification in diabetes mellitus[J]. Arterioscler Thromb Vasc Biol, 2017, 37(2): 191-204. doi: 10.1161/ATVBAHA.116.306256
[10]	吴振, 徐燕, 苏文韬, 等. 2型糖尿病合并颈动脉粥样硬化患者血清甲状旁腺激素及25羟维生素D与糖脂代谢的相关性[J]. 实用临床医药杂志, 2022, 26(17): 120-124. doi: 10.7619/jcmp.20221479
[11]	YANG Z, HAN B, ZHANG H G, et al. Association of lower extremity vascular disease, coronary artery, and carotid artery atherosclerosis in patients with type 2 diabetes mellitus[J]. Comput Math Methods Med, 2021, 2021: 6268856.
[12]	LAURANCE S, LEMARIÉ C A, BLOSTEIN M D. Growth arrest-specific gene 6 (gas6) and vascular hemostasis[J]. Adv Nutr, 2012, 3(2): 196-203. doi: 10.3945/an.111.001826
[13]	WU K S, HUNG Y J, LEE C H, et al. The involvement of GAS6 signaling in the development of obesity and associated inflammation[J]. Int J Endocrinol, 2015, 2015: 202513. http://www.onacademic.com/detail/journal_1000040465627110_7528.html
[14]	HSIAO F C, LIN Y F, HSIEH P S, et al. Circulating growth arrest-specific 6 protein is associated with adiposity, systemic inflammation, and insulin resistance among overweight and obese adolescents[J]. J Clin Endocrinol Metab, 2013, 98(2): E267-E274. doi: 10.1210/jc.2012-3179
[15]	KUO F C, HUNG Y J, SHIEH Y S, et al. The levels of plasma growth arrest-specific protein 6 is associated with insulin sensitivity and inflammation in women[J]. Diabetes Res Clin Pract, 2014, 103(2): 304-309. doi: 10.1016/j.diabres.2013.12.057
[16]	DIHINGIA A, KALITA J, MANNA P. Implication of a novel Gla-containing protein, Gas6 in the pathogenesis of insulin resistance, impaired glucose homeostasis, and inflammation: a review[J]. Diabetes Res Clin Pract, 2017, 128: 74-82. doi: 10.1016/j.diabres.2017.03.026
[17]	SCHÄFFLER A, BUECHLER C. CTRP family: linking immunity to metabolism[J]. Trends Endocrinol Metab, 2012, 23(4): 194-204. doi: 10.1016/j.tem.2011.12.003
[18]	LI Y J, YE L, JIA G W, et al. C1q/TNF-related protein 4 induces signal transducer and activator of transcription 3 pathway and modulates food intake[J]. Neuroscience, 2020, 429: 1-9. doi: 10.1016/j.neuroscience.2019.12.039
[19]	TEWHEY R, KOTLIAR D, PARK D S, et al. Direct identification of hundreds of expression-modulating variants using a multiplexed reporter assay[J]. Cell, 2016, 165(6): 1519-1529. doi: 10.1016/j.cell.2016.04.027
[20]	YE L, JIA G W, LI Y J, et al. C1q/TNF-related protein 4 restores leptin sensitivity by downregulating NF-κB signaling and microglial activation[J]. J Neuroinflammation, 2021, 18(1): 159. doi: 10.1186/s12974-021-02167-2

[1]	BAO Qingying, ZHANG Lingling, MA Songhua, CHEN Xiaobo, JIANG Zhi, JIANG Qiqun. Correlations between serum soluble growth stimulationgene 2 protein, brain natriuretic peptide and the degree of carotid atherosclerosis in patients with acute ischemic stroke[J]. Journal of Clinical Medicine in Practice, 2024, 28(8): 70-74, 78. DOI: 10.7619/jcmp.20240200
[2]	LI Qian, WANG Shuo, CHEN Yarong, LI Shan, JIN Dandan, GAO Yan. Expression and clinical significance of serum C1q/tumor necrosis factor related protein 3 in diabetes patients complicated with osteoporosis[J]. Journal of Clinical Medicine in Practice, 2023, 27(12): 57-62. DOI: 10.7619/jcmp.20230193
[3]	YAN Xiaopei, SHI Baoyu, WANG Hui, JIN Minghua, XU Xiao, XU Li. Analysis of clinical manifestation and risk factors of chronic obstructive pulmonary disease with hypertension[J]. Journal of Clinical Medicine in Practice, 2021, 25(3): 63-68. DOI: 10.7619/jcmp.20201154
[4]	XIN Suping, YE Xinhua. Study on cholesterol in middle-aged and elderly patients with type 2 diabetes mellitus complicated with carotid atherosclerosis[J]. Journal of Clinical Medicine in Practice, 2020, 24(2): 87-90. DOI: 10.7619/jcmp.202002025
[5]	JIA Shujing, SHI Chunxia, LI Lihua. Clinical significance and changes of serum high-sensitivity Creactive protein and neuron-specific enolase in acute cerebral infarction patients with different risk factors[J]. Journal of Clinical Medicine in Practice, 2019, 23(10): 61-64. DOI: 10.7619/jcmp.201910017
[6]	GAO Lin. Correlation between blood pressure variability and carotid atherosclerosis in hypertensive patients[J]. Journal of Clinical Medicine in Practice, 2016, (3): 1-3. DOI: 10.7619/jcmp.201603001
[7]	WANG Junjun, YU Chunjuan, DING Qilong, XING Ting. Correlation between serum high sensitivity C-reactive protein and atherosclerosis in patients with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2015, (5): 5-7. DOI: 10.7619/jcmp.201505002
[8]	PAN Guohua. IL-2, IL-10, TNF-α and Th1/Th2 levels in patients with pregnancy-induced hypertension syndrome[J]. Journal of Clinical Medicine in Practice, 2013, (19): 33-34,37. DOI: 10.7619/jcmp.201319011
[9]	HUANG Pei, ZHU Jing. Influences of rosuvastatin on the endothelial function and eNOS gene expression in patients with hypertension combined with atherosclerosis[J]. Journal of Clinical Medicine in Practice, 2013, (17): 5-8. DOI: 10.7619/jcmp.201317002
[10]	QU Chen. Clinical observation of the protective action of pancreatic kininogenase on vessel endothelium in elderly hypertension patients complicated with the arteriosclerosis of the lower extremities[J]. Journal of Clinical Medicine in Practice, 2012, (7): 24-26. DOI: 10.3969/j.issn.1672-2353.2012.07.007

Cited By

Cited by

Periodical cited type(13)

1.	付中英，杨燕玲，苏月华，于晗澍，李曼，朱凤芹，常红. 过敏性紫癫患儿外周血单个核细胞中ASC mRNA和NLRP3 mRNA表达水平及其与并发肾炎的关系. 中国妇幼健康研究. 2024(11): 20-31 .
2.	刘阳，郝佳，卑雪，赵志佳，李阳. 过敏性紫癜患儿幽门螺杆菌感染及其对补体系统及炎症指标的影响. 中华医院感染学杂志. 2023(01): 138-141 .
3.	郭爱玲. 学龄前期HP阳性儿童的免疫功能及生长发育的特点. 哈尔滨医药. 2023(01): 33-35 .
4.	潘馨，刘佳奕，王艳，童敏，严方利，孙香娟. 幽门螺杆菌感染与儿童过敏性紫癜相关性的Meta分析. 医学信息. 2023(02): 92-98 .
5.	黄丽琴，江秀华. 微生态制剂结合抗Hp三联方案治疗Hp阳性腹型AP患儿的效果. 数理医药学杂志. 2022(06): 893-895 .
6.	孙文，黄雅玲，高健. 腹型过敏性紫癜患儿幽门螺杆菌感染与消化道出血的关系及相关因素探讨. 现代消化及介入诊疗. 2022(03): 355-358 .
7.	王彩芳，么鑫，蔡花，张菂，黄翠影，梁晓亮，陈瑞珊，海冬. 肺炎链球菌、肺炎支原体、柯萨奇病毒及EB病毒感染与儿童过敏性紫癜肾炎的相关性研究. 临床和实验医学杂志. 2022(19): 2099-2103 .
8.	刘力铭，张颖，赵子年，杨金玉，焦丽华，刘建丽，回广飞. 过敏性紫癜患儿呼吸道病毒感染特异性免疫球蛋白M检测及血清炎性因子变化. 临床军医杂志. 2021(07): 768-769 .
9.	王杨. 过敏性紫癜患儿血清中Cys C、TM与T淋巴细胞亚群的关系及易感因素分析. 中国医学创新. 2021(21): 10-14 .
10.	王士杰，胡方起，和平，余必信，邓芳. 黄芪颗粒联合氢化可的松琥珀酸钠治疗过敏性紫癜临床疗效与安全性探究. 中华中医药学刊. 2021(09): 169-172 .
11.	王婧，韩磊，张震，夏毓，姜烜星，汤兴萍. 儿童过敏性紫癜感染幽门螺杆菌的危险因素分析与治疗研究. 系统医学. 2021(16): 31-34 .
12.	李丹，张波，秦帅，刘宇. 微生态制剂结合抗幽门螺杆菌三联方案治疗儿童幽门螺杆菌阳性腹型过敏性紫癜的疗效分析. 中国现代医学杂志. 2021(19): 44-48 .
13.	郭志伟. 探究儿童过敏性紫癜临床用药的治疗效果. 中国继续医学教育. 2021(30): 156-159 .

Other cited types(1)

Get Citation

PDF

XML

Article views (178) PDF downloads (10) Cited by(14)

Turn off MathJax

Article Contents

Abstract

References

Correlations of growth arrest specific 6 and C1q/TNF-related protein 4 with carotid atherosclerosis in patients with type 2 diabetes